Deep vein thrombosis in patients with stroke or transient ischemic attack presenting with patent foramen ovale: a

Charlotte Huber1, Stephan Stöbe2, Andreas Hagendorff2

  • 1Department of Neurology, University of Leipzig, Liebigstr. 20, 04103, Leipzig, Germany.

BMC Neurology
|August 26, 2024
PubMed

Insights

Deep vein thrombosis (DVT) occurs in a significant number of stroke patients with a patent foramen ovale (PFO). The Wells score can help identify patients who need further screening for DVT.

Area of Science:

  • Cardiology
  • Neurology
  • Vascular Medicine

Background:

  • Patent foramen ovale (PFO) is linked to paradoxical embolism causing cerebral ischemia.
  • Deep vein thrombosis (DVT) is a potential source of embolism in PFO patients, but screening rates vary.
  • Lack of clear guidelines necessitates characterizing DVT prevalence in stroke/TIA patients with PFO.

Purpose of the Study:

  • To determine the rate of DVT in patients with stroke or transient ischemic attack (TIA) and PFO.
  • To identify clinical, demographic, and laboratory parameters associated with DVT in this population.
  • To evaluate the utility of risk scores in predicting DVT.

Main Methods:

  • Retrospective analysis of medical records for patients with stroke/TIA and PFO.
  • DVT diagnosis via lower limb compression ultrasonography.
  • Comparison of demographic, clinical, laboratory data, RoPE, and Wells scores between DVT+ and DVT- groups.

Main Results:

  • 339 patients (61.2±15.4 years, 61.1% male) with stroke/TIA and PFO were identified.
  • DVT was detected in 7.8% (17/217) of patients undergoing ultrasonography.
  • DVT was associated with prior DVT, cancer, immobilization, calf pain/swelling, and elevated D-dimer. The Wells score was a significant predictor (OR 35.46).

Conclusions:

  • DVT is present in a relevant proportion of patients with cerebral ischemia and PFO.
  • Screening for DVT should be considered in the diagnostic workup of these patients.
  • The Wells score may effectively guide the need for compression ultrasonography.
Abstract

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
654
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
756